BioCryst Pharmaceuticals (MEX:BCRX) Additional Paid-In Capital : MXN26,900 Mil(As of Mar. 2025)

View and export this data going back to 2019. Start your Free Trial

What is BioCryst Pharmaceuticals Additional Paid-In Capital?

BioCryst Pharmaceuticals's quarterly additional paid-in capital increased from Sep. 2024 (MXN25,013 Mil) to Dec. 2024 (MXN26,927 Mil) but then stayed the same from Dec. 2024 (MXN26,927 Mil) to Mar. 2025 (MXN26,900 Mil).

BioCryst Pharmaceuticals's annual additional paid-in capital declined from Dec. 2022 (MXN22,579 Mil) to Dec. 2023 (MXN20,747 Mil) but then increased from Dec. 2023 (MXN20,747 Mil) to Dec. 2024 (MXN26,927 Mil).

BioCryst Pharmaceuticals Additional Paid-In Capital Historical Data

The historical data trend for BioCryst Pharmaceuticals's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

BioCryst Pharmaceuticals Additional Paid-In Capital Chart

BioCryst Pharmaceuticals Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Additional Paid-In Capital

Get a 7-Day Free Trial

19,939.90

22,534.59

22,578.67

20,746.54

26,926.79

BioCryst Pharmaceuticals Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Additional Paid-In Capital	Get a 7-Day Free Trial															20,538.48	22,918.14	25,012.94	26,926.79	26,899.61

BioCryst Pharmaceuticals Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital

(Issue Price

Par Value)

Shares Outstanding (Diluted Average)

BioCryst Pharmaceuticals Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of BioCryst Pharmaceuticals's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.

BioCryst Pharmaceuticals Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » BioCryst Pharmaceuticals Inc (MEX:BCRX) » Definitions » Additional Paid-In Capital

Comparable Companies

Traded in Other Exchanges

BCRX:USA BO1:Germany BO1:Germany

Address

4505 Emperor Boulevard, Suite 200, Durham, NC, USA, 27703

Website

https://www.biocryst.com

BioCryst Pharmaceuticals Inc is a biotechnology company involved mainly in the research and development of novel small-molecule drugs, to block key enzymes involved in infectious and inflammatory diseases. Biocryst's research is based on multiple scientific disciplines like biology, computer modeling, and medicinal chemistry. Its products and candidates target the following therapeutic areas: acute uncomplicated influenza; uncomplicated seasonal influenza; hereditary angioedema; filoviruses, including the Ebola and Marburg viruses; and oncology.